Lotus Pharma Revenue, Profits - LTUS Annual Income Statement

Add to My Stocks
$0.01 $0 (0%) LTUS stock closing price Sep 18, 2018 (Closing)

Stock analysis based on fundamentals means looking at financial statements in addition to the Lotus Pharma stock price. The key financial statements of a company are the income statement, the balance sheet and the cash flow statement. The income statement for LTUS which shows a YOY revenue growth of 25.72% is specific to a period of time. Investors typically check YoY or QoQ revenue growth. Along with Lotus Pharma assets and Lotus Pharma free cash flow, Lotus Pharma profits as shown in profit and loss statement give key insights about the business. The net profit for 2010 is $14.42M and the 2010 revenue is $72.69M.

View revenue and profit details for latest and last 10 financial years.
show more
Fiscal year is Jan - Dec201020092008
Lotus Pharma Revenues or Net Sales
72.69M57.82M73.8M
Cost Of Goods Sold (COGS)32.91M25.35M-
Lotus Pharma Gross Profit
39.78M32.47M-
Research & Development Expense---
Selling General & Admin Expense18.4M11.43M-
Income Before Depreciation Depletion Amortization21.28M21.03M-
Depreciation Depletion Amortization---
Non Operating Income-6.02M-2.08M-
Interest Expense-2.15M-
Lotus Pharma Pretax Income
14.64M16.8M-
Provision for Income Taxes---
MinorityInterest---
Investment Gains Losses---
Other Income---
Income Before Extraordinaries & Disc Operations14.42M16.43M12.79M
Extraordinary Items & Discontinued Operations---
Lotus Pharma Profit/ Loss (Net Income)
14.42M16.43M12.79M
Average Shares used to compute Diluted EPS27M25.02M24.03M
Average Shares used to compute Basic EPS26.18M22.11M21.15M
Income Before Nonrecurring Items21.19M16.43M12.79M
Income from Nonrecurring Items-6.76M--
Lotus Pharma Earnings Per Share Basic Net
0.550.740.60
Lotus Pharma Earnings Per Share Diluted Net
0.540.660.54
EPS Diluted Before Nonrecurring Items0.780.660.54
Preferred Dividends Acc Pd---
Dividends Common---
Dividend Per Share Common0.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.

Before investing one should read a report on Lotus Pharma stock analysis. It helps to look at the following income statement items:

  • Top line: The word topline comes from the fact that the first line of an income statement refers to sales numbers. If you check you will find that LTUS stock has a topline or revenue of $72.69M for 2010 as per this Lotus Pharma revenue chart. Investors look for stocks with a growing top line.
  • Bottom line: The word bottom line comes because it is usually the last line of the income statement and refers to the actual profits after deducting all expenses from the revenues. LTUS stock had a poor bottom line growth.

The income statement is also called the profit and loss statement. Apart from the LTUS income statement, one can check the Lotus Pharma historical stock prices to check how the price has moved with time.

Lotus Pharma Income Statement - Key Financial Ratios